BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 11074608)

  • 1. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
    Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
    Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.
    Kang Y; Ozbun LL; Angdisen J; Moody TW; Prentice M; Diwan BA; Jakowlew SB
    Carcinogenesis; 2002 Jul; 23(7):1217-27. PubMed ID: 12117781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis.
    Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB
    Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta expression in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Exp Lung Res; 1998; 24(4):579-93. PubMed ID: 9659584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors.
    Chen MF; Gray KD; Prentice MA; Mariano JM; Jakowlew SB
    Pediatr Res; 1999 Jul; 46(1):61-70. PubMed ID: 10400136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer.
    Zhang HT; Chen XF; Wang MH; Wang JC; Qi QY; Zhang RM; Xu WQ; Fei QY; Wang F; Cheng QQ; Chen F; Zhu CS; Tao SH; Luo Z
    Clin Cancer Res; 2004 Apr; 10(7):2359-67. PubMed ID: 15073112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
    Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
    Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras.
    McKenna IM; Ramakrishna G; Diwan BA; Kang Y; Shiao YH; Wakefield LM; Powell DA; Anderson LM; Jakowlew SB
    Toxicol Lett; 2001 Sep; 123(2-3):151-8. PubMed ID: 11641043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
    Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
    Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
    Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
    Matoba H; Sugano S; Yamaguchi N; Miyachi Y
    Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
    Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
    Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygous mice for the transforming growth factor-beta type II receptor gene have increased susceptibility to hepatocellular carcinogenesis.
    Im YH; Kim HT; Kim IY; Factor VM; Hahm KB; Anzano M; Jang JJ; Flanders K; Haines DC; Thorgeirsson SS; Sizeland A; Kim SJ
    Cancer Res; 2001 Sep; 61(18):6665-8. PubMed ID: 11559531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased transforming growth factor beta type II receptor expression in intestinal adenomas from Min/+ mice is associated with increased cyclin D1 and cyclin-dependent kinase 4 expression.
    Zhang T; Nanney LB; Peeler MO; Williams CS; Lamps L; Heppner KJ; DuBois RN; Beauchamp RD
    Cancer Res; 1997 May; 57(9):1638-43. PubMed ID: 9134999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
    Nørgaard P; Spang-Thomsen M; Poulsen HS
    Br J Cancer; 1996 May; 73(9):1037-43. PubMed ID: 8624260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model.
    Pu H; Collazo J; Jones E; Gayheart D; Sakamoto S; Vogt A; Mitchell B; Kyprianou N
    Cancer Res; 2009 Sep; 69(18):7366-74. PubMed ID: 19738062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.